S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
Critical asset just had biggest fall on record (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
Critical asset just had biggest fall on record (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
Critical asset just had biggest fall on record (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
Critical asset just had biggest fall on record (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024

Privia Health Group (PRVA) Stock Price, News & Analysis

$20.00
+0.51 (+2.62%)
(As of 02/26/2024 ET)
Today's Range
$19.59
$20.21
50-Day Range
$19.31
$24.22
52-Week Range
$19.17
$30.15
Volume
1.77 million shs
Average Volume
1.00 million shs
Market Capitalization
$2.36 billion
P/E Ratio
64.52
Dividend Yield
N/A
Price Target
$32.90

Privia Health Group MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.89 Rating Score
Upside/​Downside
60.9% Upside
$32.18 Price Target
Short Interest
Bearish
7.09% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.49mentions of Privia Health Group in the last 14 days
Based on 13 Articles This Week
Insider Trading
Selling Shares
$516,812 Sold Last Quarter
Proj. Earnings Growth
47.62%
From $0.21 to $0.31 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.94 out of 5 stars

Medical Sector

191st out of 942 stocks

Health Services Industry

1st out of 10 stocks


PRVA stock logo

About Privia Health Group Stock (NASDAQ:PRVA)

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. is a subsidiary of Brighton Health Group Holdings, LLC.

PRVA Stock Price History

PRVA Stock News Headlines

Privia Health Gr's Earnings: A Preview
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Privia Health Group Inc (PRVA)
Privia Health Group (PRVA) to Release Quarterly Earnings on Tuesday
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
PRVA Mar 2024 25.000 call
RBC Capital Reaffirms Their Buy Rating on Privia Health Group (PRVA)
Privia Health Group Inc.
Truist Financial Keeps Their Buy Rating on Privia Health Group (PRVA)
BTIG Reaffirms Their Buy Rating on Privia Health Group (PRVA)
BTIG Keeps Their Buy Rating on Privia Health Group (PRVA)
Privia Health Group Inc PRVA
Privia Health Group Inc
Q3 2023 Privia Health Group Inc Earnings Call
See More Headlines
Receive PRVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Privia Health Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/03/2023
Today
2/26/2024
Next Earnings (Confirmed)
2/27/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Health services
Sub-Industry
N/A
Current Symbol
NASDAQ:PRVA
Fax
N/A
Employees
964
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$32.18
High Stock Price Target
$41.00
Low Stock Price Target
$21.00
Potential Upside/Downside
+65.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.89
Research Coverage
10 Analysts

Profitability

Net Income
$-8,590,000.00
Pretax Margin
1.78%

Debt

Sales & Book Value

Annual Sales
$1.36 billion
Book Value
$4.53 per share

Miscellaneous

Free Float
65,171,000
Market Cap
$2.34 billion
Optionable
Optionable
Beta
0.80
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report














PRVA Stock Analysis - Frequently Asked Questions

Should I buy or sell Privia Health Group stock right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Privia Health Group in the last twelve months. There are currently 1 hold rating and 9 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" PRVA shares.
View PRVA analyst ratings
or view top-rated stocks.

What is Privia Health Group's stock price target for 2024?

10 brokerages have issued 12-month target prices for Privia Health Group's stock. Their PRVA share price targets range from $21.00 to $41.00. On average, they expect the company's stock price to reach $32.18 in the next twelve months. This suggests a possible upside of 60.9% from the stock's current price.
View analysts price targets for PRVA
or view top-rated stocks among Wall Street analysts.

How have PRVA shares performed in 2024?

Privia Health Group's stock was trading at $23.03 on January 1st, 2024. Since then, PRVA shares have decreased by 13.2% and is now trading at $20.00.
View the best growth stocks for 2024 here
.

Are investors shorting Privia Health Group?

Privia Health Group saw a increase in short interest in January. As of January 31st, there was short interest totaling 7,210,000 shares, an increase of 15.2% from the January 15th total of 6,260,000 shares. Based on an average daily volume of 789,500 shares, the days-to-cover ratio is currently 9.1 days. Currently, 7.1% of the company's stock are sold short.
View Privia Health Group's Short Interest
.

When is Privia Health Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024.
View our PRVA earnings forecast
.

How can I listen to Privia Health Group's earnings call?

Privia Health Group will be holding an earnings conference call on Tuesday, February 27th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Privia Health Group's earnings last quarter?

Privia Health Group, Inc. (NASDAQ:PRVA) released its quarterly earnings data on Friday, November, 3rd. The company reported $0.05 EPS for the quarter, meeting the consensus estimate of $0.05. The company earned $417.30 million during the quarter, compared to the consensus estimate of $410.51 million. Privia Health Group had a net margin of 2.40% and a trailing twelve-month return on equity of 6.80%. The business's revenue was up 21.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.01 EPS.

When did Privia Health Group IPO?

(PRVA) raised $351 million in an IPO on Thursday, April 29th 2021. The company issued 19,500,000 shares at $17.00-$19.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse, Piper Sandler and William Blair acted as the underwriters for the IPO and Canaccord Genuity, Truist Securities, R. Seelaus & Co. and Siebert Williams Shank were co-managers.

Who are Privia Health Group's major shareholders?

Privia Health Group's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (9.55%), Riverbridge Partners LLC (3.89%), Riverbridge Partners LLC (3.68%), Principal Financial Group Inc. (2.97%), Northern Trust Corp (1.15%) and Franklin Resources Inc. (1.15%). Insiders that own company stock include Advisors LLC Mbd, David Mountcastle, Jeffrey B Butler, Jeffrey Daniel Bernstein, Matthew Shawn Morris, Pamplona Capital Partners Iii,, Parth Mehrotra, Thomas Bartrum and William M Sullivan.
View institutional ownership trends
.

How do I buy shares of Privia Health Group?

Shares of PRVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PRVA) was last updated on 2/27/2024 by MarketBeat.com Staff